4-methyltetrazolo[1,5-a]quinoline | 72716-16-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 4-methyltetrazolo[1,5-a]quinoline
• CAS: 72716-16-6
• 化学式: C₁₀H₈N₄
• 分子量: 184.2
• InChiKey: UYDRJFLSJSYBMP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  43.1
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  (Z)-3-(2-azidophenyl)-2-methylprop-2-enenitrile 以 甲苯 为溶剂， 反应 0.5h， 以83%的产率得到4-methyltetrazolo[1,5-a]quinoline
  参考文献：
  名称：

  Thermochemical behavior of o-azidocinnamonitriles

  摘要：

  DOI：

  10.1021/jo01311a044

文献信息

• [EN] SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION<br/>[FR] COMPOSÉS BENZALDÉHYDE SUBSTITUÉS ET PROCÉDÉS D'UTILISATION DE CEUX-CI DANS L'AUGMENTATION DE L'OXYGÉNATION DES TISSUS
  申请人：GLOBAL BLOOD THERAPEUTICS INC

  公开号：WO2013102142A1

  公开（公告）日：2013-07-04

  Provided are substituted benzaldehydes and derivatives thereof that act as allosteric modulators of hemoglobin, methods and intermediates for their preparation, pharmaceutical compositions comprising the modulators, and methods for their use in treating disorders mediate by hemoglobin and disorders that would benefit from increased tissue oxygenation.

  提供了替代苯甲醛及其衍生物，其作为血红蛋白的变构调节剂，以及其制备的方法和中间体，包括这些调节剂的药物组合物，以及在治疗由血红蛋白介导的疾病和需要增加组织氧合的疾病中使用它们的方法。
• Novel synthesis of 2-aminoquinoline-3-carbaldehyde, benzo[<i>b</i> ][1,8]naphthyridines and study of their fluorescence behavior
  作者：Deepak P. Shelar、Dilip R. Birari、Ramhari V. Rote、Sandeep R. Patil、Raghunath B. Toche、Madhukar N. Jachak

  DOI：10.1002/poc.1727

  日期：2011.3

  A novel route was successfully developed for the synthesis of new synthons, orthoamino formyl quinoline (heterocyclic orthoaminoaldehyde) and utilized for the synthesis of series of benzonaphthyridines by Friedländer condensation reactions with benzoylacetonitrile. The benzonaphthyridines synthesized were further studied for their fluorescence properties. Copyright © 2010 John Wiley & Sons, Ltd.

  已成功开发了一条新路线，用于合成新的合成子，原氨基甲酰基喹啉（杂环原氨基醛），并用于与苯甲酰基乙腈的弗里德兰德缩合反应用于合成一系列苯并萘啶。进一步研究了合成的苯并萘啶的荧光性质。版权所有©2010 John Wiley＆Sons，Ltd.
• HCV Inhibitors And Methods Of Using Them
  申请人：Thota Sambaiah

  公开号：US20070149520A1

  公开（公告）日：2007-06-28

  The present invention comprises tetrazoloquinoline-compounds that are inhibitors of HCV. Compositions comprising the compounds in combination with a pharmaceutically acceptable carrier are also disclosed, as are methods of using the compounds and compositions to inhibit HCV infection of a cell, particular in the form of treating HCV infection in a mammal.

  本发明涉及四唑喹啉类化合物，其为HCV抑制剂。本发明还涉及将该化合物与药学上可接受的载体组合而成的组合物，以及使用该化合物和组合物抑制细胞的HCV感染的方法，特别是用于治疗哺乳动物的HCV感染。
• SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
  申请人：Global Blood Therapeutics, Inc.

  公开号：US20130190315A1

  公开（公告）日：2013-07-25

  Provided are substituted benzaldehydes and derivatives thereof that act as allosteric modulators of hemoglobin, methods and intermediates for their preparation, pharmaceutical compositions comprising the modulators, and methods for their use in treating disorders mediate by hemoglobin and disorders that would benefit from increased tissue oxygenation.

  提供一种替代苯甲醛及其衍生物，其作为血红蛋白的异构调节剂，以及其制备的方法和中间体，包括该调节剂的制药组合物，以及使用该组合物治疗由血红蛋白介导的疾病和需要增加组织氧合的疾病的方法。
• INTERMEDIATES TO OBTAIN SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
  申请人：Global Blood Therapeutics, Inc.

  公开号：EP3738434A1

  公开（公告）日：2020-11-18

  Provided are substituted benzaldehydes and derivatives thereof that act as allosteric modulators of hemoglobin, methods and intermediates for their preparation, pharmaceutical compositions comprising the modulators, and methods for their use in treating disorders mediate by hemoglobin and disorders that would benefit from increased tissue oxygenation.

  本文提供了可作为血红蛋白异位调节剂的取代苯甲醛及其衍生物、制备它们的方法和中间体、包含这些调节剂的药物组合物，以及将它们用于治疗由血红蛋白介导的疾病和可从增加组织含氧量中获益的疾病的方法。